期刊文献+

白藜芦醇三甲醚脂质体的制备及其质量评价 被引量:4

Preparation of resveratrol trimethyl ether liposomes and their quality evaluation
原文传递
导出
摘要 目的制备白藜芦醇三甲醚(BTM)脂质体,对其质量特性进行评价,并考察脂质体对BTM的增溶作用。方法采用薄膜分散法制备BTM脂质体,以包封率为评价指标,通过正交试验设计优化处方工艺,微柱离心法测定其包封率,观察其形态、粒径及稳定性,并考察其对BTM的增溶作用。结果优化的最佳处方工艺为BTM与卵磷脂质量比为1∶20,胆固醇与卵磷脂质量比为1∶4,水化介质为5%甘露醇;按该处方制备的BTM脂质体包封率达(86.4±2.2)%;与游离BTM相比,BTM脂质体在水中的溶解度增大了1 012倍。结论采用最佳处方制备得到的BTM脂质体包封率较高,形态和粒径较均匀,并且可以较好地提高BTM的溶解度。 Objective To prepare resveratrol trimethyl ether (3, 5, 4'-trimethoxy-trans-stilbene, BTM) liposomes, evaluate their quality, and observe the solubilization of BTM. Methods The film dispersion method was used to prepare BTM liposomes. Orthogonal test design was used to optimize the formula by taking encapsulation efficiency (EE) as index. The EE was determined by the microcolumn centrifugation method. The properties of liposomes including morphology, mean diameter, stability, and solubilization of BTM were studied. Results The best prescription was BTM-phospholipid (1 : 20), Cholesterol-phospholipid (1:4), and 5% mannitol as hydration medium. The EE of the prepared BTM liposomes was (86.4±2.2)%, and the solubility of BTM was increased by 1 012 times compared with free BTM. Conclusion The BTM liposomes prepared according to the optimized formula have the higher EE and the uniform morphology and diameter. Liposomes could improve the solubility of BTM.
机构地区 中南大学药学院
出处 《中草药》 CAS CSCD 北大核心 2012年第9期1746-1750,共5页 Chinese Traditional and Herbal Drugs
关键词 白藜芦醇三甲醚(BTM) 薄膜分散法 微柱离心法 包封率 正交试验设计 resveratrol trimethyl ether (3, 5, 4'-trimethoxy-trans-stilbene, BTM) film dispersion method microcolumn centrifugation encapsulation efficiency (EE) orthogonal test design
  • 相关文献

参考文献14

  • 1Yuan Q, Peng J, Liu S Y, et al. Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway [J]. Clin Exp Pharmacol Physiol, 2010, 37(5/6): 630-635.
  • 2Pan M H, Gao J H, Lai C S, et al. Antitumor activity of 3, 5, 4'-trimethoxystilbene in COLO 205 cells and xenografts in SCID mice [J]. Mol Carcinog, 2008, 47(3): 184-196.
  • 3Li L, Luo X J, Liu Y Z, et al. The role of the DDAH- ADMA pathway in the protective effect of resveratrolanalog BTM-0512 on gastric mucosal injury [J]. Can J Physiol Pharmacol, 2010, 88(5): 562-567.
  • 4吕春艳,李芳,张兰桐.天然产物中二苯乙烯类化合物的研究近况与开发前景[J].河北医科大学学报,2009,30(2):213-216. 被引量:2
  • 5Ioele G; Cione E, Risoli A, et al. Accelerated photostability study of tretinoin and isotretinoin in liposome formulations [J]. Int J Pharm, 2005, 293(1/2): 251-260.
  • 6韩文霞,李伟泽,汪兴军,张寒,孙艳平,郝保华.盐酸青藤碱纳米柔性脂质体的制备及其性质研究[J].中草药,2011,42(4):671-675. 被引量:24
  • 7Lu Y, Li J, Wang G J. In vitro and in vivo evaluation of mPEG-PLA modified liposomes loaded glycyrrhetinic acid [J]. IntJPharm, 2008, 356(1/2): 274-281.
  • 8琚辉,郝存江,尹飞,宋丽丽,陈春林,肖婷.姜黄素固体脂质纳米粒的制备及表征[J].药物评价研究,2010,33(6):420-423. 被引量:29
  • 9Di Venosa C- Herrnida L, Batlle A, et al. Characterisation of liposomes containing aminolevulinic acid and derived esters [J]. JPhotochem Photobiol B, 2008, 92(1): 1-9.
  • 10Bhatia A, Kumar R, Katare O P. Tamoxifen in topical liposomes: development, characterization and in vitro evaluation [J]. JPharm Pharm Sci, 2004, 7(2): 252-259.

二级参考文献84

共引文献117

同被引文献61

  • 1刘爱娜,陈昊,唐星.黄芪甲苷脂质微球注射液的制备及其物理稳定性研究[J].中国药剂学杂志(网络版),2009(4):290-298. 被引量:4
  • 2苏立平,薛明明,陈立,苏立军,祁朋,何蕾.蛇床子素对大鼠肝癌动物模型肝细胞生物行为学特性及血管特征的影响[J].中国生化药物杂志,2014,34(6):35-37. 被引量:8
  • 3沈丽霞,金乐群,张丹参,常洁琴.蛇床子素的抗实验性心律失常作用[J].张家口医学院学报,2001,18(1):9-10. 被引量:15
  • 4Xinli Liang, Mengliang Zhu, Yunchao Cao, et al. Preparation, Charac- Lerization evaluation of Tanshinone IIA lipid microspere and compara- :ive study of pharmacokinetics with Sodium Tanshinone IIA Sulfonate injection[ J ]. Advanced Materials Research Vols, 2013 (781 - 784 ) :1044 -1051.
  • 5Medina J, Salvado A, Pozo AD. Use of ultrasound to prepare lipid e- mulsions of lorazepam for intravenous injection[ J]. Int J Pharm,2001, 216:1 -8.
  • 6Liu Y, Lin X, Tang X. Lipid emulsions as a potential delivery system for ocular use of azithromyein[ J]. Drug Dev Ind Phann,2009,35 (7) : 887 - 896.
  • 7Yue P F, Yuan H L, Li X Y, et al. Development and optimization of intravenous puerarin emulsions formation by a novel complex-phase in- version-homogenization technology [ J ]. Chem Pharm Bull, 2007,55 (11) :1563 -1568.
  • 8Gallegos C, Partal P, France JM. Droplet-size distribution and stabili- ty of lipid injeetable emulsions [ J ]. Am J Health Syst Pharm, 2009, 66 : 162 - 166.
  • 9Jang J H, Kim C K, Choi H G, et al. Preparation and evaluation of 2- (allylthio) pyrazine-loadwd lipid emulsion with enhanced tability and livertageting[ J]. Drug Dev Ind Phann,2009,35:363 -368.
  • 10Seki J, Sonokea S, Saheki A, et al. Ananometer lipid emulsion, lipid nano-sphere( LNS ), as a parenteral drug carri-erfor passive drug targeting[ J]./nt J Pharm ,2004,273 ( 1 - 2 ) :75 - 83.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部